Understanding how LSD affects serotonin receptors in the brain
Mechanistic insights into LSD actions at 5-HT2A serotonin receptors
This study is looking at how LSD and similar psychedelic drugs work in the brain by exploring their effects on serotonin receptors, which could help us understand how these substances might impact mental health and behavior.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11036392 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms by which LSD and similar psychedelic drugs interact with serotonin receptors in the brain. By studying both human and rodent receptors, the research aims to uncover how these substances influence gene transcription in neurons. The approach includes in vitro and in vivo experiments to provide detailed insights into the actions of these drugs at the molecular level. This could lead to a better understanding of the effects of psychedelics on mental health and behavior.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing anxiety or other mental health issues who may benefit from novel therapeutic approaches.
Not a fit: Patients who do not have any mental health conditions or those who are not interested in psychedelic treatments may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for anxiety and other mental health conditions by leveraging the effects of psychedelics.
How similar studies have performed: Other research has shown promising results in understanding the therapeutic potential of psychedelics, indicating that this approach is building on a growing body of evidence.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Roth, Bryan L. — Univ of North Carolina Chapel Hill
- Study coordinator: Roth, Bryan L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.